GW9662, a potent antagonist of PPARgamma, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARgamma agonist rosiglitazone, independently of PPARgamma activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples